# Granulocytapheresis in Psoriasis

> **NCT00714272** · NA · TERMINATED · sponsor: **EXcorLab GmbH** · enrollment: 4 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DEVICE:** Treatment with a Granulocyte Adsorber, Medica Adsorber 1.1
- **DEVICE:** Treatment with a sham device, EXcorLab box 1.2

## Key facts

- **NCT ID:** NCT00714272
- **Lead sponsor:** EXcorLab GmbH
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02-18
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Primary outcome not achieved.
- **Last updated:** 2020-08-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00714272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00714272, "Granulocytapheresis in Psoriasis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00714272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*